摘要
目的:探讨急性心肌梗死溶栓治疗中瑞替普酶与尿激酶应用的效果。方法:收治急性心肌梗死患者102例,随机分为对照组和观察组,分别采用尿激酶和瑞替普酶治疗,比较两组治疗效果。结果:观察组溶栓再通效果和并发症发生率明显优于对照组(P<0.05)。结论:瑞替普酶在急性心肌梗死溶栓治疗中的效果显著。
Objective:To explore the application effect of reteplase and urokinase in thrombolytic therapy of acute myocardialinfarction.Methods:102patients with acute myocardial infarction were selected.They were randomly divided into the control groupand the observation group.Two groups were treated respectively with urokinase and reteplase.We compared the therapeutic effectof two groups.Results:The effect of thrombolysis and recanalization and complication rate of the observation group were obviouslybetter than those of the control group(P<0.05).Conclusion:The application effect of reteplase in thrombolytic therapy of acutemyocardial infarction was significant.
作者
梁文强
洪芳
Liang Wenqiang;Hong Fang(The Third People's Hospital of Yuxi City,653100)
出处
《中国社区医师》
2017年第28期58-58,60,共2页
Chinese Community Doctors
关键词
急性心肌梗死
瑞替普酶
尿激酶
Acute myocardial infarction
Reteplase
Urokinase